Evidence map›Paper›PMID 25535027›Full record

ArticleMolecular bioSystems2015

Correction: A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered berberine.

Shenghua Gu, Bei Cao, Runbin Sun, Yueqing Tang, Janice L Paletta, Xiao-Lei Wu, Linsheng Liu, Weibin Zha, Chunyan Zhao, Yan Li and 5 more

Registry-linked trialAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Molecular bioSystems, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03438292 (To Test the Efficacy of Novel Berberine Emulsification by TPGS or Quillaja Extract on the Absorption of Berberine Compared to Berberine Powder in Humans), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03438292 nacompletednot on this mapstarted 2018, after this paper: background citation

To Test the Efficacy of Novel Berberine Emulsification by TPGS or Quillaja Extract on the Absorption of Berberine Compared to Berberine Powder in Humans

TypeinterventionalSponsorUniversity of FloridaRan2018 to 2020Enrolled32ConditionsHealthyArmsBerberine, TPGS emulsified berberine, Quillaja extract emulsified berberine
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Shenghua GuState Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism and Pharmacokinetics, Jiangsu Key laboratory of drug design and optimization, China Pharmaceutical University, Nanjing 210009, China. jiyea@cpu.edu.cn.
Bei Cao
Runbin Sun
Yueqing Tang
Janice L Paletta
Xiao-Lei Wu
Linsheng Liu
Weibin Zha
Chunyan Zhao
Yan Li
Jason M Ridlon
Phillip B Hylemon
Huiping Zhou
Jiye Aa
Guangji Wang

Funding

Prevent HIV protease inhibitor-induced atherosclerosis by BerberineR01AT004148 · NCCIH · VIRGINIA COMMONWEALTH UNIVERSITY · PI ZHOU, HUIPING ROSE · 2007 to 2010
$1.4M
NCCIH NIH HHS R01 AT004148
6 · The paper itself

Abstract

Correction for 'A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered berberine' by Shenghua Gu et al., Mol. BioSyst., 2015, DOI: .

Identifiers

PMID25535027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.